Delivery Order SPE2DB20D3303-SPE2DB25FY6M7

Award Date 12/18/24
Potential Completion Date 12/19/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FY6M7
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,690.00 firm fixed-price delivery order is for the provision of the drug product Contrave ER 8-90 mg Tablet in quantities of 120 per container.

The contract does not have a set-aside designation, indicating open competition. It is associated with AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

These contracts demonstrate AmerisourceBergen's critical role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The company's extensive distribution capabilities and broad portfolio of pharmaceutical and medical products enable efficient government procurement of essential medical supplies to serve the healthcare needs of service members, veterans, and other federal beneficiaries.

Generated 3/19/25, 9:45 AM